STOCK TITAN

Utmost Group files Schedule 13G disclosing TLSI stake of 2.0M shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Utmost Group PLC reports beneficial ownership of 2,000,588 shares of TriSalus Life Sciences Inc. common stock, representing 0.0529% of the outstanding class. The filing states Utmost has sole voting and dispositive power over all reported shares and identifies Lombard International Assurance SA as a subsidiary acquired by Utmost on 30/12/2024. The disclosure explains the percentage ownership fell because TriSalus’ total outstanding shares increased to 37,838,962. The filing is a Schedule 13G indicating passive reporting under the Exchange Act rules and includes Utmost’s UK address and an authorized signature by the Group CFO dated 08/11/2025.

Positive

  • Clear disclosure of beneficial ownership: 2,000,588 shares with sole voting and dispositive power
  • Compliance with reporting rules via Schedule 13G and identification of subsidiary (Lombard International Assurance SA)

Negative

  • De minimis economic/ownership impact: stake represents only 0.0529% of the class
  • Dilution noted: percentage ownership fell because outstanding shares increased to 37,838,962

Insights

TL;DR: Small passive stake disclosed; ownership is non-controlling and diluted by a larger share count.

The filing shows Utmost Group PLC holds 2,000,588 shares (0.0529%), with sole voting and dispositive power, which confirms clear internal control over these holdings despite the stake being immaterial to corporate control. The note that ownership percentage decreased because outstanding shares rose to 37,838,962 is important for context: absolute share count is unchanged while relative influence fell. For investors, this is a routine disclosure under Schedule 13G rather than an activist or control filing.

TL;DR: Governance implication minimal: Utmost reports sole authority on a very small, likely passive position.

The report classifies the filer as a foreign institution and documents subsidiary involvement






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The ownership of Lombard International Assurance SA (part of Utmost Group) in TriSalus Life Sciences Inc. has decreased due to fact that the number of outstanding shares of TriSalus Life Sciences Inc. has increased to 37,838,962.


SCHEDULE 13G



Utmost Group PLC
Signature:/s/ lan Maidens
Name/Title:lan Maidens - Group CFO
Date:08/11/2025

FAQ

How many TriSalus (TLSI) shares does Utmost Group PLC report owning?

Utmost Group PLC reports beneficial ownership of 2,000,588 shares.

What percentage of TLSI does Utmost Group PLC own?

The filing states Utmost owns 0.0529% of TriSalus Life Sciences Inc. common stock.

Does Utmost Group PLC have voting control over its TLSI shares?

Yes. The filing shows Utmost has sole voting power and sole dispositive power over the 2,000,588 shares.

Why did Utmost’s percentage ownership change?

The filing explains the percentage declined because TriSalus’ total outstanding shares increased to 37,838,962.

Is this a Schedule 13G or 13D filing and what does that imply?

This is a Schedule 13G, which typically indicates a passive or non-activist reporting position under the Exchange Act rules.

Which subsidiary is identified in the filing related to Utmost’s ownership?

The filing identifies Lombard International Assurance SA, acquired by Utmost on 30/12/2024, as the relevant subsidiary.
TriSalus Life Sciences Inc.

NASDAQ:TLSI

TLSI Rankings

TLSI Latest News

TLSI Latest SEC Filings

TLSI Stock Data

293.29M
28.03M
40.92%
17.25%
0.92%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
WESTMINSTER